OpenLobby.EU
Explore

SERB France

SERB

SERB began in the 1950s in France as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research).

Lobbying Activity

Meeting with Boriša Falatar (Cabinet of Commissioner Hadja Lahbib)

3 Jul 2025 · EU CBRN preparedness strategy and the role of the pharmaceutical industry

Response to EU Strategy on medical countermeasures

9 May 2025

Please find attached SERB Pharmaceuticals' feeback to the consultation on the strategy to support medical countermeasures against public health threats, in both French and English.
Read full response

Response to Communication on the EU Stockpiling Strategy

9 May 2025

Please find attached SERB Pharmaceuticals' feeback to the consultation on the new EU stockpiling strategy, in both French and English.
Read full response